inveox
inveox automates pathology labs to prevent cancer misdiagnosis and improve lab efficiency.
inveox has raised €17M across 1 funding round, most recently a Series A round in Oct 2019. Based in Garching Bei München, Germany; founded 2017; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€17M
€17,000,000
Funding rounds
1
Investors
0
distinct backers
Active since
2019-10
latest 2019-10
Funding by year
EUR raised per yearinveox — funding by year — interactive chart.
Data table
| inveox — funding by year | |
|---|---|
| 2019 | €17M |
Signals
Medium confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-10-01 | Series A | €17M | — | View deal → |
Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData